D. Chu

669 total citations · 1 hit paper
6 papers, 507 citations indexed

About

D. Chu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, D. Chu has authored 6 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in D. Chu's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (2 papers). D. Chu is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (2 papers). D. Chu collaborates with scholars based in China, Taiwan and Hong Kong. D. Chu's co-authors include James Chih‐Hsin Yang, Chris Brown, Chee Khoon Lee, Chun‐Ming Tsai, Adel Zaatar, Akira Inoue, Siow Ming Lee, Joseph S. K. Au, Richard J. Gralla and Jcm Ho and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and European Journal of Cancer.

In The Last Decade

D. Chu

5 papers receiving 498 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

2013 383 citations Chee Khoon Lee, Chris Brown et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Chu China	5	430	358	127	108	27	6	507
Adel Zaatar Australia	5	376 0.9×	328 0.9×	126 1.0×	105 1.0×	28 1.0×	9	476
She-Juan An China	6	362 0.8×	281 0.8×	138 1.1×	139 1.3×	31 1.1×	7	453
Changli Wang China	13	450 1.0×	346 1.0×	89 0.7×	114 1.1×	26 1.0×	29	522
Kosei Tajima Japan	8	611 1.4×	529 1.5×	150 1.2×	98 0.9×	21 0.8×	15	706
Norihiro Yamaguchi United States	6	312 0.7×	233 0.7×	156 1.2×	149 1.4×	17 0.6×	7	451
Pei Ni Ding Australia	5	311 0.7×	230 0.6×	124 1.0×	143 1.3×	16 0.6×	6	402
Eric D. Mininberg United States	3	307 0.7×	345 1.0×	192 1.5×	96 0.9×	27 1.0×	6	494
KS Albain United States	8	427 1.0×	488 1.4×	111 0.9×	107 1.0×	37 1.4×	18	607
Daniela Iacono Italy	9	266 0.6×	228 0.6×	141 1.1×	64 0.6×	24 0.9×	19	372
Kunitoshi Tomii Japan	4	480 1.1×	389 1.1×	269 2.1×	150 1.4×	18 0.7×	7	658

Countries citing papers authored by D. Chu

Since Specialization

Citations

This map shows the geographic impact of D. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Chu more than expected).

Fields of papers citing papers by D. Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Chu. The network helps show where D. Chu may publish in the future.

Co-authorship network of co-authors of D. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of D. Chu. A scholar is included among the top collaborators of D. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Chu. D. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Lee, Chee Khoon, Chris Brown, Richard J. Gralla, et al.. (2013). Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis. JNCI Journal of the National Cancer Institute. 105(9). 595–605. 383 indexed citations breakdown →

2.

Wu, Yi‐Long, N. Saijo, Sumitra Thongprasert, et al.. (2011). 9132 POSTER Efficacy Outcomes in First-line Treatment of Advanced NSCLC With Gefitinib (G) vs Carboplatin/paclitaxel (C/P) by Epidermal Growth Factor Receptor (EGFR) Gene-copy Number Score and by Most Common EGFR Mutation Subtypes – Exploratory Data From IPASS. European Journal of Cancer. 47. S633–S633. 5 indexed citations

3.

Wu, Yi‐Long, Tony Mok, D. Chu, et al.. (2009). Evaluation of clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) recruited in China in a phase III, randomized, open-label, first-line study in Asia of gefitinib (G) versus carboplatin/paclitaxel (C/P) (IPASS). Journal of Clinical Oncology. 27(15_suppl). 8041–8041. 10 indexed citations

4.

Fukuoka, M., Yi‐Cheng Wu, S. Thongprasert, et al.. (2009). Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS). Journal of Clinical Oncology. 27(15_suppl). 8006–8006. 95 indexed citations

5.

Guan, Zhong Zhen, et al.. (2005). [Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial].. PubMed. 24(8). 980–4. 13 indexed citations

6.

Chu, D., et al.. (1999). TURNING TECHNIQUE OF ELITE SWIMMERS IN BUTTERFLY AND BREASTSTROKE. ISBS - Conference Proceedings Archive. 1(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact